Compare $ATNM vs $CVM | Chartloom

Compare

$ATNM vs $CVM

Actinium Pharmaceuticals Inc · CEL-SCI Corp

ATNM

Actinium Pharmaceuticals Inc

CVM

CEL-SCI Corp

Compare $ATNM vs $CVM

Comparing Actinium Pharmaceuticals Inc and CEL-SCI Corp

ATNMActinium Pharmaceuticals Inc

CVMCEL-SCI Corp

ATNMActinium Pharmaceuticals Inc

Market cap

$35M

P/E (TTM)

3.06x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-19.7%

52W performance

-28.6%

FCF yield

-67.4%

CVMCEL-SCI Corp

Market cap

$34M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-62.3%

52W performance

-80.7%

FCF yield

-49.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ATNM

CVM

Detailed metrics comparison

ATNM

Actinium Pharmaceuticals Inc

CVM

CEL-SCI Corp

Market Cap

ATNM$35M

CVM$34M

Enterprise Value

ATNM$-2M

CVM$34M

Price

ATNM$1.10

CVM$1.94

P/E Ratio

ATNM3.06x

CVMN/A

P/S Ratio

ATNM0.98x

CVM72.73x

EV/Sales

ATNM-0.06x

CVM72.27x

EV/EBITDA

ATNM-0.20x

CVM0.00x

P/B Ratio

ATNM1.21x

CVM3.71x

P/FCF Ratio

ATNMN/A

CVMN/A

EV/FCF

ATNM0.08x

CVM-2.01x

PEG Ratio

ATNMN/A

CVMN/A

Forward P/E (NTM)

ATNMN/A

CVMN/A

Forward P/S (NTM)

ATNMN/A

CVMN/A

Revenue (TTM)

ATNM$35M

CVM$0

Revenue Growth (YoY)

ATNMN/A

CVMN/A

Forward Rev Growth

ATNM-0.2%

CVM0.0%

Gross Margin (TTM)

ATNM0.0%

CVM0.0%

Operating Margin (TTM)

ATNM62.3%

CVM0.0%

EBITDA Margin (TTM)

ATNM27.9%

CVM0.0%

Net Margin (TTM)

ATNM32.2%

CVM0.0%

FCF Margin (TTM)

ATNM-66.2%

CVMN/A

Net Income (TTM)

ATNM$11M

CVM$-23M

FCF (TTM)

ATNM$-23M

CVM$-17M

EPS (TTM)

ATNM$0.36

CVM-$1.87

ROE (TTM)

ATNM83.4%

CVM-20214.0%

ROA (TTM)

ATNM23.4%

CVM-10078.0%

ROIC (TTM)

ATNM83.4%

CVM-12370.0%

Cash

ATNM$36M

CVM$7M

Debt

ATNM$5K

CVM$6M

Net Cash/Debt

ATNM$36M

CVM$256K

Current Ratio (TTM)

ATNM4.08x

CVM1.48x

Quick Ratio (TTM)

ATNM3.94x

CVM1.29x

Debt/Equity (TTM)

ATNM0.00x

CVM0.57x

Debt/Assets (TTM)

ATNM0.0%

CVM0.0%

Interest Coverage (TTM)

ATNMN/A

CVMN/A

Net Debt/EBITDA (TTM)

ATNM0.00x

CVM0.00x

Beta

ATNM0.33

CVM0.62

52W Performance

ATNM-28.6%

CVM-80.7%

YTD Performance

ATNM-19.7%

CVM-62.3%

% from 52W High

ATNM-36.8%

CVM-81.3%

% from 52W Low

ATNM49.6%

CVM118.0%

Asset Turnover (TTM)

ATNM0.73x

CVM0.01x

FCF Yield (TTM)

ATNM-67.4%

CVM-49.4%

Earnings Yield (TTM)

ATNM32.8%

CVM-67.0%

Dividend Yield (TTM)

ATNMN/A

CVMN/A

Rule of 40

ATNM-66.2

CVM0.0

EV/GP/RG

ATNMN/A

CVMN/A

Ticker research

View ATNM research View CVM research

Metric	ATNM Actinium Pharmaceuticals Inc	CVM CEL-SCI Corp
Market & Valuation
Market Cap	$35M	$34M
Enterprise Value	$-2M	$34M
Price	$1.10	$1.94
P/E Ratio	3.06x	N/A
P/S Ratio	0.98x	72.73x
EV/Sales	-0.06x	72.27x
EV/EBITDA	-0.20x	0.00x
P/B Ratio	1.21x	3.71x
P/FCF Ratio	N/A	N/A
EV/FCF	0.08x	-2.01x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$35M	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	-0.2%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	62.3%	0.0%
EBITDA Margin (TTM)	27.9%	0.0%
Net Margin (TTM)	32.2%	0.0%
FCF Margin (TTM)	-66.2%	N/A
Net Income (TTM)	$11M	$-23M
FCF (TTM)	$-23M	$-17M
EPS (TTM)	$0.36	-$1.87
ROE (TTM)	83.4%	-20214.0%
ROA (TTM)	23.4%	-10078.0%
ROIC (TTM)	83.4%	-12370.0%
Financial Health
Cash	$36M	$7M
Debt	$5K	$6M
Net Cash/Debt	$36M	$256K
Current Ratio (TTM)	4.08x	1.48x
Quick Ratio (TTM)	3.94x	1.29x
Debt/Equity (TTM)	0.00x	0.57x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.33	0.62
52W Performance	-28.6%	-80.7%
YTD Performance	-19.7%	-62.3%
% from 52W High	-36.8%	-81.3%
% from 52W Low	49.6%	118.0%
Efficiency & Yields
Asset Turnover (TTM)	0.73x	0.01x
FCF Yield (TTM)	-67.4%	-49.4%
Earnings Yield (TTM)	32.8%	-67.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-66.2	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ATNM research	View CVM research

Valuation

P/E Ratio

ATNM

3.06x

P/S Ratio

ATNM

0.98x

CVM

72.73x

EV/FCF

CVM

-2.01x

ATNM

0.08x

Growth & revenue

Forward Revenue Growth

CVM

0.0%

ATNM

-0.2%

Profitability & performance

Gross Margin

ATNM

0.0%

CVM

0.0%

ROE

ATNM

83.4%

CVM

-20214.0%

FCF Yield %

CVM

-49.4%

ATNM

-67.4%

52-Week Performance

ATNM

-28.6%

CVM

-80.7%

Detailed metrics comparison

ATNM

Actinium Pharmaceuticals Inc

CVM

CEL-SCI Corp

Market Cap

ATNM$35M

CVM$34M

Enterprise Value

ATNM$-2M

CVM$34M

Price

ATNM$1.10

CVM$1.94

P/E Ratio

ATNM3.06x

CVMN/A

P/S Ratio

ATNM0.98x

CVM72.73x

EV/Sales

ATNM-0.06x

CVM72.27x

EV/EBITDA

ATNM-0.20x

CVM0.00x

P/B Ratio

ATNM1.21x

CVM3.71x

P/FCF Ratio

ATNMN/A

CVMN/A

EV/FCF

ATNM0.08x

CVM-2.01x

PEG Ratio

ATNMN/A

CVMN/A

Forward P/E (NTM)

ATNMN/A

CVMN/A

Forward P/S (NTM)

ATNMN/A

CVMN/A

Revenue (TTM)

ATNM$35M

CVM$0

Revenue Growth (YoY)

ATNMN/A

CVMN/A

Forward Rev Growth

ATNM-0.2%

CVM0.0%

Gross Margin (TTM)

ATNM0.0%

CVM0.0%

Operating Margin (TTM)

ATNM62.3%

CVM0.0%

EBITDA Margin (TTM)

ATNM27.9%

CVM0.0%

Net Margin (TTM)

ATNM32.2%

CVM0.0%

FCF Margin (TTM)

ATNM-66.2%

CVMN/A

Net Income (TTM)

ATNM$11M

CVM$-23M

FCF (TTM)

ATNM$-23M

CVM$-17M

EPS (TTM)

ATNM$0.36

CVM-$1.87

ROE (TTM)

ATNM83.4%

CVM-20214.0%

ROA (TTM)

ATNM23.4%

CVM-10078.0%

ROIC (TTM)

ATNM83.4%

CVM-12370.0%

Cash

ATNM$36M

CVM$7M

Debt

ATNM$5K

CVM$6M

Net Cash/Debt

ATNM$36M

CVM$256K

Current Ratio (TTM)

ATNM4.08x

CVM1.48x

Quick Ratio (TTM)

ATNM3.94x

CVM1.29x

Debt/Equity (TTM)

ATNM0.00x

CVM0.57x

Debt/Assets (TTM)

ATNM0.0%

CVM0.0%

Interest Coverage (TTM)

ATNMN/A

CVMN/A

Net Debt/EBITDA (TTM)

ATNM0.00x

CVM0.00x

Beta

ATNM0.33

CVM0.62

52W Performance

ATNM-28.6%

CVM-80.7%

YTD Performance

ATNM-19.7%

CVM-62.3%

% from 52W High

ATNM-36.8%

CVM-81.3%

% from 52W Low

ATNM49.6%

CVM118.0%

Asset Turnover (TTM)

ATNM0.73x

CVM0.01x

FCF Yield (TTM)

ATNM-67.4%

CVM-49.4%

Earnings Yield (TTM)

ATNM32.8%

CVM-67.0%

Dividend Yield (TTM)

ATNMN/A

CVMN/A

Rule of 40

ATNM-66.2

CVM0.0

EV/GP/RG

ATNMN/A

CVMN/A

Ticker research

View ATNM research View CVM research

Metric	ATNM Actinium Pharmaceuticals Inc	CVM CEL-SCI Corp
Market & Valuation
Market Cap	$35M	$34M
Enterprise Value	$-2M	$34M
Price	$1.10	$1.94
P/E Ratio	3.06x	N/A
P/S Ratio	0.98x	72.73x
EV/Sales	-0.06x	72.27x
EV/EBITDA	-0.20x	0.00x
P/B Ratio	1.21x	3.71x
P/FCF Ratio	N/A	N/A
EV/FCF	0.08x	-2.01x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$35M	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	-0.2%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	62.3%	0.0%
EBITDA Margin (TTM)	27.9%	0.0%
Net Margin (TTM)	32.2%	0.0%
FCF Margin (TTM)	-66.2%	N/A
Net Income (TTM)	$11M	$-23M
FCF (TTM)	$-23M	$-17M
EPS (TTM)	$0.36	-$1.87
ROE (TTM)	83.4%	-20214.0%
ROA (TTM)	23.4%	-10078.0%
ROIC (TTM)	83.4%	-12370.0%
Financial Health
Cash	$36M	$7M
Debt	$5K	$6M
Net Cash/Debt	$36M	$256K
Current Ratio (TTM)	4.08x	1.48x
Quick Ratio (TTM)	3.94x	1.29x
Debt/Equity (TTM)	0.00x	0.57x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.33	0.62
52W Performance	-28.6%	-80.7%
YTD Performance	-19.7%	-62.3%
% from 52W High	-36.8%	-81.3%
% from 52W Low	49.6%	118.0%
Efficiency & Yields
Asset Turnover (TTM)	0.73x	0.01x
FCF Yield (TTM)	-67.4%	-49.4%
Earnings Yield (TTM)	32.8%	-67.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-66.2	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ATNM research	View CVM research